Restorative Therapies

Restorative Therapies is a private U.S. medical device company focused on neurorehabilitation using integrated Functional Electrical Stimulation (FES) systems for use in clinics and at home. Its commercial portfolio includes the RT300 FES Cycle and the Xcite2 therapy system, both FDA Class II-cleared devices designed to improve muscle activation, functional movement, and recovery in people with neurological impairment or paralysis. The company positions its products as evidence-based rehabilitation tools for conditions including spinal cord injury, stroke, multiple sclerosis, traumatic brain injury, and critical illness. Restorative Therapies also provides clinician training, reimbursement support, home-therapy workflows, and international distribution. Founded in 2004, the company traces its origins to work by researchers, engineers, and patient advocates seeking to expand access to activity-based restorative therapy and FES.